Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 25, 2022
Ajinomoto Bio-Pharma Services announced that Tony O'Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations. Mr. O'Neill brings extensive experience leading Quality, Manufacturing, and Operational Excellence Teams in the ...
read more
Tuesday, January 25, 2022
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing services, has appointed Laura Jacanin as Senior Director of ...
read more
Tuesday, January 25, 2022
Mindset Pharma Inc. has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO), for the production of pharmaceutical grade batches of Mindset’s next-generation psilocybin drug ...
read more
Tuesday, January 25, 2022
Sharp has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands.
read more
Wednesday, January 19, 2022
Charles River Laboratories International, Inc. and Valo Health, LLC announced the formation of a multiyear strategic partnership. This agreement will combine Valo’s Opal Computational Platform with Charles River’s drug discovery and development ...
read more
Wednesday, January 19, 2022
Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site...
read more
Wednesday, January 19, 2022
Forbion, BioGeneration Ventures and Lonza announced the extension of their collaboration to include the development and manufacturing of small molecules.
read more
Wednesday, January 19, 2022
In a broad career, Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham PLC, and CEO at Cadus Pharmaceutical in the US.
read more
Wednesday, January 19, 2022
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced the launch of its new Xpress ...
read more
Wednesday, January 19, 2022
Recro Pharma, Inc. announced the appointment of Eduardo Uribe as the company’s head of quality for Recro San Diego. Mr. Uribe has more than 30 years of experience developing, implementing and managing quality systems within the biotechnology and ...
read more
Wednesday, January 19, 2022
Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data has announced the expansion of its range of clinical consulting services. In addition to the services already offered by Congenica, the Company has ...
read more
Wednesday, January 19, 2022
PhoreMost Ltd., has relocated its headquarters to Unity Campus, a high-specification technology and innovation park, owned by leading regional property developers and investors, Howard Group, in south Cambridge.
read more
Wednesday, January 19, 2022
Treadwell Therapeutics, a clinical stage, multi-modality biotechnology company developing novel therapeutics for highly aggressive cancers, and Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) have confirmed...
read more
Wednesday, January 19, 2022
Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH announced their unified operations and re-brand as ProtaGene, a CRO partner for the biopharmaceutical and cell & gene therapy industries.
read more
Thursday, January 13, 2022
Procaps Group announced the closing of an asset purchase agreement to acquire an 86,000 sq. ft. pharmaceutical production facility located in Florida with production capacity of approximately 1.8 billion capsules per year.
read more